[1] Januškevičienė I, Petrikaitė V. Heterogeneity of breast cancer: the importance of interaction between different tumor cell populations. Life Sci, 2019; 239, 117009. doi:  10.1016/j.lfs.2019.117009
[2] Emadi A, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol, 2009; 6, 638−47. doi:  10.1038/nrclinonc.2009.146
[3] Kurauchi K, Nishikawa T, Miyahara E, et al. Role of metabolites of cyclophosphamide in cardiotoxicity. BMC Res Notes, 2017; 10, 406. doi:  10.1186/s13104-017-2726-2
[4] Trueba GP, Sánchez GM, Giuliani A. Oxygen free radical and antioxidant defense mechanism in cancer. Front Biosci, 2004; 9, 2029−44. doi:  10.2741/1335
[5] Liu ZW, Ren ZP, Zhang J, et al. Role of ROS and nutritional antioxidants in human diseases. Front Physiol, 2018; 9, 477. doi:  10.3389/fphys.2018.00477
[6] Yang HT, Villani RM, Wang HL, et al. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res, 2018; 37, 266. doi:  10.1186/s13046-018-0909-x
[7] Turati F, Rossi M, Pelucchi C, et al. Fruit and vegetables and cancer risk: a review of southern European studies. Br J Nutr, 2015; 113, S102−10. doi:  10.1017/S0007114515000148
[8] Ren M, Yang SJ, Li JH, et al. Ginkgo biloba L. extract enhances the effectiveness of syngeneic bone marrow mesenchymal stem cells in lowering blood glucose levels and reversing oxidative stress. Endocrine, 2013; 43, 360‐9.